Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Journal of Chemotherapy (Florence, Italy)|December 19, 2025
The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre studyBilgeşah Kılıçtaş, Murat Araz, Ahmet Oruç, et al.Journal of Chemotherapy (Florence, Italy)|September 11, 2024
Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinomaHasan Cagri Yildirim, Ertuğrul Bayram, Elvin Chalabiyev, et al.Scientific Reports|April 5, 2025
Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancerYasin Sezgin, Oğur Karhan, Mehmet Naci Aldemir, et al.Future Oncology (London, England)|October 17, 2025
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access programDeniz Tural, Oğuzcan Özkan, Eda Eylemer Mocan, et al.Clinical Genitourinary Cancer|June 25, 2026
Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the LiteratureCevat İlteriş Kıkılı, Murat Araz, Yüksel Ürün, et al.Journal of Cancer Research and Therapeutics|December 13, 2022
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology groupCihan Erol, Mehmet Ali Nahit Sendur, Irem Bilgetekin, et al.Therapeutic Advances in Medical Oncology|March 16, 2026
Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter studyTaha Koray Sahin, Fatih Kemik, Harun Muglu, et al.JCO Global Oncology|March 26, 2026
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO)Erman Akkus, Mehmet Kayaalp, Müzeyyen Aslı Ergözoğlu, et al.International Journal of Cancer|June 29, 2026
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study (TOG/GI-SAFRADJU-2501)Erman Akkus, Mehmet Kayaalp, Müzeyyen Aslı Ergözoğlu, et al.Pageof 9